Table 1.
Patients’ characteristics.
| Characteristics | MDT cohort, N = 229 (%) | Non-MDT cohort, N = 294 (%) | p value |
|---|---|---|---|
| Gender | |||
| Male | 142 (62) | 171 (58.2) | 0.373 |
| Female | 87 (38) | 123 (41.8) | |
| Age | |||
| Median years (IQR) | 64 (57–71) | 64 (56–70) | 0.563 |
| < 60 years | 77 (33.6) | 106 (36) | 0.712 |
| ≥ 60 years | 152 (66.4) | 188 (64) | |
| Onset of metastases | |||
| Synchronous | 141 (61.6) | 183 (62.2) | 0.875 |
| Metachronous | 88 (38.4) | 111 (37.8) | |
| Number of metastases at diagnosis | |||
| Mean (95% CI) | 3.9 (3.4–4.3) | 2.8 (2.4–3.1) | < 0.001 |
| Single metastasis | 85 (37.1) | 127 (43.2) | |
| 2–3 metastases | 59 (25.8) | 99 (33.7) | < 0.015* |
| > 3 metastases | 85 (37.1) | 68 (23.1) | |
| Size of metastases at diagnosis | |||
| Mean (95%CI) | 4 (3.6–4.4) | 3.7 (3.4–4.0) | 0.170 |
| ≤ 3 cm | 105 (45.9) | 158 (53.7) | 0.073 |
| > 3 cm | 124 (54.1) | 136 (46.3) | |
| Location of metastases | |||
| Monolobar | 120 (52.4) | 174 (59.2) | 0.121 |
| Bilobar | 109 (47.6) | 120 (40.8) | |
IQR interquartile range, 95% CI 95% confidence interval.
*Statistically significant.